Efficacy of Yellow Cassava to Improve Vitamin A Status of Kenyan School Children (CASSAVITA)
Primary Purpose
Vitamin A Deficiency
Status
Completed
Phase
Not Applicable
Locations
Kenya
Study Type
Interventional
Intervention
Yellow cassava
White cassava
White cassava
Sponsored by
About this trial
This is an interventional prevention trial for Vitamin A Deficiency focused on measuring Vitamin A deficiency, Biofortification, Cassava, B-carotene, School children, Kenya
Eligibility Criteria
Inclusion Criteria:
- Low vitamin A status (retinol binding protein (RBP) at the lowest end of the distribution will be included in the study)
Exclusion Criteria:
- History or signs of infectious or systemic diseases (e.g. tuberculosis, sickle cell anaemia)
- Anaemia, malaria or acute inflammation at the day of baseline measurements
Sites / Locations
- Kibwezi District
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Placebo Comparator
Active Comparator
Arm Label
Yellow cassava + placebo capsule
White cassava + placebo capsule
White cassava + B-carotene capsule
Arm Description
Outcomes
Primary Outcome Measures
Change in serum retinol concentration
Secondary Outcome Measures
Immune function indicators
neopterin, IL-2, IL4, IL10, IL13, TNF-a, IFN-γ, TGF-β in serum; IgA in saliva
Bioefficacy
Comparison of change in serum retinol between yellow cassava group and positive control (B-carotene supplement group)
Functional indicators
Gut integrity, dark adaptation, morbidity
Thyroid function
Serum Tg, TSH
Effect modification
Serum zinc, serum retinol, iron status, polymorphisms
Anemia
Hemoglobin
Full Information
NCT ID
NCT01614483
First Posted
June 1, 2012
Last Updated
November 16, 2022
Sponsor
Wageningen University
Collaborators
European Commission, University of Nairobi
1. Study Identification
Unique Protocol Identification Number
NCT01614483
Brief Title
Efficacy of Yellow Cassava to Improve Vitamin A Status of Kenyan School Children
Acronym
CASSAVITA
Official Title
Efficacy of Yellow Cassava to Improve Vitamin A Status of Mildly Deficient Primary School Children in Kenya: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wageningen University
Collaborators
European Commission, University of Nairobi
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The overall aim of the project is to provide proof-of-principle that biofortification of cassava with vitamin A is a viable strategy to improve vitamin A status of deficient populations.
Detailed Description
Rationale: Vitamin A deficiency is still common in developing countries and has been proven difficult to combat. A promising approach is to replace common crops with varieties that are naturally richer in vitamin A, which is referred to as biofortification. For cassava, yellow β-carotene rich varieties have recently been introduced in Kenya, and these varieties are now ready to be tested for their efficacy to improve vitamin A status in humans.
Objective: The primary objective is to measure the effect of daily consumption of provitamin A biofortified cassava (providing 50% of the age-specific RDA) on vitamin A status in children aged 5-13 years with mild to moderate vitamin A deficiency in Kenya. To determine the bioefficacy of provitamin A carotenoids from biofortified cassava relative to that of a daily B-carotene supplement (comparison with positive control group). Secondary objectives are: 1) to measure the effect of the intervention on immune function indicators and morbidity; 2) to determine to what degree the serum retinol response to the intervention depends on serum concentrations of retinol and zinc at baseline; 3) to determine the effect of the intervention on functional indicators such as dark adaptation capacity, gut integrity, hematology indicators and thyroid status; 4) to determine the mediating effect of SNP's in the BCMO1 gene on treatment outcome.
Study design & Study population : In this randomized controlled trial, school children aged 5-13 years living in the Kibwezi area, Kenya. Children will be selected from three (or four) primary schools in the area that have been pre-selected based on the prevalence of vitamin A deficiency, location and willingness to participate.
Intervention: After screening for eligibility and a 2-week run-in period (n=360) Children will be randomly allocated to three different treatments: 1) 400 g of yellow cassava providing ~50% of the RDA for vitamin A; and a placebo capsule; 2) 400 g of white cassava; and a placebo capsule; 3) 400 g of white cassava and a capsule containing 100 RAE of all-trans β-carotene.
Main study parameters/endpoints: The main outcome measure will be differences in serum retinol concentrations between groups. Other outcome measures include other vitamin A status indicators (β-carotene, retinol binding protein, transthyretin), immune function indicators, dark adaptation, iron status indicators, anthropometrics, gut integrity, and thyroid function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin A Deficiency
Keywords
Vitamin A deficiency, Biofortification, Cassava, B-carotene, School children, Kenya
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
341 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Yellow cassava + placebo capsule
Arm Type
Experimental
Arm Title
White cassava + placebo capsule
Arm Type
Placebo Comparator
Arm Title
White cassava + B-carotene capsule
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Yellow cassava
Intervention Description
Daily provision of 375 g boiled yellow cassava for 18 weeks, 6 days/week Daily provision of placebo capsule for 18 weeks, 6 days/week
Intervention Type
Other
Intervention Name(s)
White cassava
Intervention Description
Daily provision of 375 g boiled white cassava for 18 weeks, 6 days/ week Daily provision of placebo capsule for 18 weeks, 6 days/ week
Intervention Type
Other
Intervention Name(s)
White cassava
Intervention Description
Daily provision of 375 g boiled white cassava for 18 weeks, 6 days/week Daily provision of B-carotene capsule (1400 µg B-carotene)
Primary Outcome Measure Information:
Title
Change in serum retinol concentration
Time Frame
Baseline, end of study (4 months)
Secondary Outcome Measure Information:
Title
Immune function indicators
Description
neopterin, IL-2, IL4, IL10, IL13, TNF-a, IFN-γ, TGF-β in serum; IgA in saliva
Time Frame
End of study (4 months)
Title
Bioefficacy
Description
Comparison of change in serum retinol between yellow cassava group and positive control (B-carotene supplement group)
Time Frame
Baseline, end of study (4 months)
Title
Functional indicators
Description
Gut integrity, dark adaptation, morbidity
Time Frame
End of study (4 months)
Title
Thyroid function
Description
Serum Tg, TSH
Time Frame
End of study (4 months
Title
Effect modification
Description
Serum zinc, serum retinol, iron status, polymorphisms
Time Frame
Baseline
Title
Anemia
Description
Hemoglobin
Time Frame
End of study (4 months)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
61 Months
Maximum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Low vitamin A status (retinol binding protein (RBP) at the lowest end of the distribution will be included in the study)
Exclusion Criteria:
History or signs of infectious or systemic diseases (e.g. tuberculosis, sickle cell anaemia)
Anaemia, malaria or acute inflammation at the day of baseline measurements
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alida Melse, PhD
Organizational Affiliation
Wageningen University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kibwezi District
City
Kibwezi
State/Province
Eastern Kenya
Country
Kenya
12. IPD Sharing Statement
Citations:
PubMed Identifier
26675768
Citation
Talsma EF, Brouwer ID, Verhoef H, Mbera GN, Mwangi AM, Demir AY, Maziya-Dixon B, Boy E, Zimmermann MB, Melse-Boonstra A. Biofortified yellow cassava and vitamin A status of Kenyan children: a randomized controlled trial. Am J Clin Nutr. 2016 Jan;103(1):258-67. doi: 10.3945/ajcn.114.100164. Epub 2015 Dec 16.
Results Reference
background
PubMed Identifier
24023681
Citation
Talsma EF, Melse-Boonstra A, de Kok BP, Mbera GN, Mwangi AM, Brouwer ID. Biofortified cassava with pro-vitamin A is sensory and culturally acceptable for consumption by primary school children in Kenya. PLoS One. 2013 Aug 30;8(8):e73433. doi: 10.1371/journal.pone.0073433. eCollection 2013.
Results Reference
background
PubMed Identifier
28965533
Citation
Talsma EF, Borgonjen-van den Berg KJ, Melse-Boonstra A, Mayer EV, Verhoef H, Demir AY, Ferguson EL, Kok FJ, Brouwer ID. The potential contribution of yellow cassava to dietary nutrient adequacy of primary-school children in Eastern Kenya; the use of linear programming. Public Health Nutr. 2018 Feb;21(2):365-376. doi: 10.1017/S1368980017002506. Epub 2017 Oct 2.
Results Reference
background
Learn more about this trial
Efficacy of Yellow Cassava to Improve Vitamin A Status of Kenyan School Children
We'll reach out to this number within 24 hrs